Medicrea International Stock price

Equities

ALMED

FR0004178572

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Medicrea International -0.58% +134.69%
Sales 2018 32.28M 34.84M Sales 2019 32.72M 35.31M Capitalization 47.7M 51.48M
Net income 2018 -11M -11.87M Net income 2019 -15M -16.19M EV / Sales 2018 1.95 x
Net Debt 2018 25.78M 27.82M Net Debt 2019 52.75M 56.93M EV / Sales 2019 3.07 x
P/E ratio 2018
-3.01 x
P/E ratio 2019
-3.06 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 3.49%
More Fundamentals * Assessed data
Dynamic Chart
Covidien Group S.a.r.l. completed the acquisition of 96.7% stake in Medicrea International SA. CI
Medicrea International SA Announces Sales Results for the Third Quarter and Year to Date Ended September 30, 2020 CI
Medtronic : to Buy Medicrea International for $154 Million DJ
Covidien Group S.a.r.l. entered into a tender offer agreement to acquire 96.7% stake in Medicrea International SA for approximately €140 million. CI
The MEDICREA Group Reports Sales Results for the Month and First Half Ended June 2020 CI
Medicrea International SA Reports Sales Results for the First Quarter and Year to Date Ended March 15, 2020 CI
MEDICREA® Announces FDA Clearance of the First Patient-Matched Spinal Interbody Cages CI
Medicrea International Sa Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Medicrea International SA Announces Sales Results for the Third Quarter and Nine Months Ended on September 30, 2019 CI
Medicrea Reports Earnings Results for the Half Year Ended June 30, 2019 CI
The MEDICREA® Group Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI Platform Technology CI
The Medicrea Group Reports Sales Results for the First Half 2019 CI
The Medicrea Group Reports Unaudited Earnings Results for the First Quarter of 2019 CI
The MEDICREA Group Enhances Proprietary UNiD ASI Service Platform with the Addition of an FDA-Cleared Device Planning and Selection Service CI
Medicrea International SA Reports Sales Results for the First Quarter of 2019 CI
More news
Managers TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
More insiders
Medicrea International SA is a France-based company that specializes in the design and manufacture of medical devices. The Company's product range includes polyaxial implants, impacted lumbar cage, polyaxial spine system, cervical compressive staples, cervical IBD, Lumbar IBD, cervical cage and bone substitutes. The Company has manufacturing facilities in La Rochelle, France. It is operational through such subsidiaries as Medicrea UK, based in the United Kingdom, Medicrea USA, based in the United States and Medicrea Technologies, based in France.
More about the company
  1. Stock
  2. Equities
  3. Stock Medicrea International - Euronext Paris